LINX versus fundoplication for treating gastro-oesophageal reflux (GERD)
Official title: Double-blind Randomised Controlled Trial for Treatment of Gastro-Oesophageal Reflux Disease; LINX Management System vs. Fundoplication (GOLF)
Run by University of Oxford · NCT07093359 · Data updated 2026-11-12
This trial will test whether the LINX magnetic ring or traditional fundoplication works better for adults with reflux (GERD) who need surgery.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 460 (estimated) |
| Sponsor | University of Oxford Academic / other |
| Locations | 5 sites (Oxford, Oxfordshire and 4 other locations) |
| Status | Recruiting |
| Started | March 6, 2025 |
| Main results expected | February 2029 |
| Study ends | July 2029 |
| Registry record updated | August 5, 2025 |
| Trial ID | NCT07093359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with symptomatic, objectively confirmed GORD who are inadequately controlled by or intolerant of medical therapy, have a hiatal hernia ≤5 cm, adequate oesophageal motility, are fit for general anaesthesia, and have no prior anti-reflux surgery.
✕Probably not a fit
Patients with large hiatal hernias (>5 cm), poor oesophageal motility, previous anti-reflux or gastric surgery, allergies to device metals, or who are unfit for general anaesthesia are unlikely to be eligible or to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with symptomatic, objectively confirmed gastro-oesophageal reflux disease who are being considered for anti-reflux surgery are offered either a laparoscopic or robotic LINX device or a laparoscopic or robotic fundoplication. Eligible participants must be 18 or older, have objective evidence of reflux, a hiatal hernia no larger than 5 cm, and adequate oesophageal motility, while prior anti-reflux surgery excludes patients. The trial compares symptom control, quality of life, and surgical complications such as gas bloat and swallowing difficulty between the two surgical approaches. The programme is led by the University of Oxford in collaboration with major UK centres.
Why it matters
Potential benefit: If successful, LINX could provide similar reflux control to fundoplication with fewer side effects such as gas bloating and difficulty swallowing.
How similar studies have gone: Previous studies suggest LINX may reduce some complications and offer similar quality-of-life improvement compared with fundoplication, but high-quality comparative evidence remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years and above 2. Willing and able to give informed consent 3. Patients with GORD insufficiently controlled by medical therapy or intolerance to medical therapy being considered for anti-reflux surgery 4. Symptomatic and objectively defined GORD; endoscopy with appearances or biopsies consistent with reflux oesophagitis, or 24-hour pH study or BRAVO test of the oesophagus consistent with GORD 5. No hiatal hernia or hiatal hernia \<5 cm in length 6. Adequate lower oesophageal motility as defined by preoperative oesophageal manometry study. Oesophageal manometry will show a mean contractile amplitude of \>30 mmHg or DCI \>450 mmHg-s-cm in 70% of swallows. Exclusion Criteria: 1. Unsuitable for surgical intervention due to medical conditions precluding general anaesthesia 2. Suspected or known allergies to titanium, stainless steel, nickel, or ferrous materials 3. Previous anti-reflux or gastric surgery 4. Previous or planned neurosurgical intervention 5. Oesophageal manometry showing complete absence of lower oesophageal contractility
Where it's running
-
Guy's and St Thomas's NHS Foundation Trust, Guy's and St Thomas's Hospital
Oxford, Oxfordshire, United Kingdom Recruiting -
Imperial College Healthcare NHS Trust, St Mary's Hospital
Oxford, Oxfordshire, United Kingdom Recruiting -
Leeds Teaching Hospitals NHS Trust, St James's University Hospital
Oxford, Oxfordshire, United Kingdom Recruiting -
Oxford University Hospitals NHS Foundation Trust, Churchill Hospital
Oxford, Oxfordshire, United Kingdom Recruiting -
University Hospital Southampton NHS Foundation Trust
Oxford, Oxfordshire, United Kingdom Recruiting
Study contacts
- Study coordinator: Sheraz Markar, PhD, FRCS, MSc, MA
- Email: golf@nds.ox.ac.uk
- Phone: +44 07584039433
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Newborn SMA Screening Service Evaluation
This project tests newborn SMA screening to see if it works well and is acceptable to families in the UK.
-
Prucalopride for low mood: testing a 5-HT4 receptor activator for cognition and sleep
This study tests whether prucalopride, a 5-HT4 receptor drug, can improve thinking and sleep in adults with low mood or major depressive disorder compared to a placebo.
-
Robotic-assisted tPA injection for retinal vein occlusion
This trial tests whether robot-assisted delivery of a clot-dissolving drug (tPA) into a blocked retinal vein can restore blood flow in people with central retinal vein occlusion.
-
Understanding heart artery disease using biomarkers and imaging in Oxford
Researchers in Oxford are testing how biomarkers and advanced imaging can help explain why some heart artery plaques are unstable and how this affects heart damage after a heart attack.
-
VTA real-time biofeedback with 7-Tesla MRI in depression
This study tests whether people with major depressive disorder can learn to modulate their brain's reward center (the VTA) using real-time feedback during 7-Tesla MRI sessions, to see if it changes mood and motivation.
-
Gut leakage in dengue: is the intestinal barrier affected during infection?
Researchers are studying whether dengue infection disrupts the gut barrier and if that contributes to severe disease in adults with dengue who are in hospital.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.